Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

Semaglutide, the popular anti-obesity drug ... a parcel of fats and protein in the blood – do not cause type 2 diabetes. Heart experts say that everyone should have their levels of lipoprotein ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

MADRID — The benefits of semaglutide treatment in reducing kidney disease ... The overall findings from the landmark FLOW ...

"In patients with obesity who were prescribed semaglutide or liraglutide ... What Is a Health Savings Account? Glucagon-like peptide-1 receptor agonists (GLP-1 agonists) are medications prescribed ...

The C-peptide test helps your doctor identify whether you have type 1 diabetes (when the immune system attacks and destroys cells in the pancreas) or type 2 diabetes (when your body doesn't use ...

Incretin therapies based on GLP-1 receptor agonism aid in the loss of weight in obesity, but a relevant part of this loss (25%-40%) is attributed to loss of lean muscle mass, which raises the risk of ...

Doctors have called GLP-1 medications — including semaglutide brand names Ozempic and Wegovy — “miracle drugs” for weight loss, offering a potential solution to Tennessee’s obesity ...

A peptide is a short chain of two or more amino acids linked by a chemical bond called a peptide bond. When organized into complex structures (typically consisting of 50 or more amino acids), peptides ...

In patients with renal insufficiency associated with increased hemoglobin levels and polycythemia, the possibilities of recombinant erythropoietin overdosing and disorders such as neoplasms and ...